Literature DB >> 1939101

An antibody that inhibits the binding of diphtheria toxin to cells revealed the association of a 27-kDa membrane protein with the diphtheria toxin receptor.

R Iwamoto1, H Senoh, Y Okada, T Uchida, E Mekada.   

Abstract

A monoclonal antibody that blocks the binding of diphtheria toxin to Vero cells was isolated by immunizing mice with Vero cell membrane. The antibody inhibits the binding of diphtheria toxin and also CRM197, a mutant form of diphtheria toxin, to Vero cells, and consequently inhibits the cytotoxicity of diphtheria toxin. This antibody does not directly react with the receptor molecule of diphtheria toxin (DTR14.5). Immunoprecipitation and immunoblotting studies revealed that this antibody binds to a novel membrane protein of 27 kDa (DRAP27). When diphtheria toxin receptor was passed through an affinity column made with this antibody, the receptor was trapped only in the presence of DRAP27. These results indicate that DRAP27 and DTR14.5 closely associate in Vero cell membrane and that the inhibition of the binding of diphtheria toxin to the receptor is due to the binding of the antibody to the DRAP27 molecule. Binding studies using 125I-labeled antibody showed that there are many more molecules of DRAP27 on the cell surface than diphtheria toxin-binding sites. However, there is a correlation between the sensitivity of a cell line to diphtheria toxin and the number of DRAP27 molecules on the cell surface, suggesting that DRAP27 is involved in the entry of diphtheria toxin into the target cell.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939101

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding.

Authors:  A de Parseval; D L Lerner; P Borrow; B J Willett; J H Elder
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Role of CD11b/CD18 in the process of intoxication by the adenylate cyclase toxin of Bordetella pertussis.

Authors:  Joshua C Eby; Mary C Gray; Annabelle R Mangan; Gina M Donato; Erik L Hewlett
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

3.  The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release.

Authors:  Robin N Prince; Eric R Schreiter; Peng Zou; H Steven Wiley; Alice Y Ting; Richard T Lee; Douglas A Lauffenburger
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

4.  Expression and distribution of CD9 in myelin of the central and peripheral nervous systems.

Authors:  Y Nakamura; R Iwamoto; E Mekada
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  Role of membrane-anchored heparin-binding epidermal growth factor-like growth factor and CD9 on macrophages.

Authors:  N Ouchi; S Kihara; S Yamashita; S Higashiyama; T Nakagawa; I Shimomura; T Funahashi; K Kameda-Takemura; S Kawata; N Taniguchi; Y Matsuzawa
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

6.  Hypersensitivity to diphtheria toxin by mouse cells expressing both diphtheria toxin receptor and CD9 antigen.

Authors:  J G Brown; B D Almond; J G Naglich; L Eidels
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

Review 7.  Targeting of tetraspanin proteins--potential benefits and strategies.

Authors:  Martin E Hemler
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

8.  Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity.

Authors:  R Iwamoto; S Higashiyama; T Mitamura; N Taniguchi; M Klagsbrun; E Mekada
Journal:  EMBO J       Date:  1994-05-15       Impact factor: 11.598

9.  Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.

Authors:  K Nakamura; R Iwamoto; E Mekada
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

10.  The 27-kD diphtheria toxin receptor-associated protein (DRAP27) from vero cells is the monkey homologue of human CD9 antigen: expression of DRAP27 elevates the number of diphtheria toxin receptors on toxin-sensitive cells.

Authors:  T Mitamura; R Iwamoto; T Umata; T Yomo; I Urabe; M Tsuneoka; E Mekada
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.